NewsSOS
Purcell & Lefkowitz LLP disclosed Sunday it is investigating AN2 Therapeutics, Inc.
(NASDAQ: ANTX) on behalf of the company's shareholders, with the inquiry focused on whether the biotech's directors breached their fiduciary duties.
The New York law firm provided no further detail on what specific conduct or corporate action prompted the probe.
The inquiry The investigation centers on potential fiduciary duty breaches by AN2 Therapeutics's board of directors, according to the firm's announcement.
Keep reading